Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite ...

In March 2025, Celgene announced a study is to compare the effectiveness and safety of golcadomide in combination with ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

CD3 T-cell engagers have the potential to be a cornerstone of cancer treatment. They guide the immune system to find and ...